Figure 4From: Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1/2 and p38 MAPK activation Effects of bilobalide on the levels of SOD and MDA. (A) Pretreatment with bilobalide (5, 10 mg/kg) significantly increased SOD activity (B) and decreased MDA concentration compared with the MCAO/R group. Mean values ± standard error of the mean for six rats per group. ** P < 0.01 versus sham; # P < 0.05, ## P < 0.01 versus MCAO/R. BB, bilobalide; MCAO/R, middle cerebral artery occlusion and reperfusion; NMP, nimodipine.Back to article page